catechin has been researched along with Hepatoblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eichenmüller, M; Gödeke, J; Kappler, R; Maier, S; Müller-Höcker, J; von Schweinitz, D | 1 |
1 other study(ies) available for catechin and Hepatoblastoma
Article | Year |
---|---|
Epigallocatechin-3-gallate inhibits hepatoblastoma growth by reactivating the Wnt inhibitor SFRP1.
Topics: Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Gene Silencing; Hepatoblastoma; Humans; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Poly(ADP-ribose) Polymerases; Wnt Signaling Pathway | 2013 |